$HNGE

Mecklenburg Gabriel M.I. sold $3.2M of HNGE

Mecklenburg Gabriel M.I. sold 49,470 shares of Hinge Health, Inc. (HNGE) at $65.53 ($3.24M total) on 2026-06-05 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Mecklenburg Gabriel M.I.
Published Jun 6, 2026, 12:16 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 6, 2026, 12:32 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$HNGE
Neutral
medium confidence
Mentioned
$HNGE
Relevance
7/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$HNGENeutralLow
01

Why it matters

The disclosure provides a datapoint on insider activity but does not, by itself, indicate a new operational or financial catalyst.

02

Market read

Insider selling can influence short-term sentiment, but 10b5-1 plans typically mean the transaction is pre-scheduled.

03

What to watch

Consider whether the director’s remaining holdings are small/large relative to prior disclosures and whether there are concurrent buys/sales in other Form 4 filings.

Relevance 7/10Novelty 4/10Timing: Filed for a sale executed on 2026-06-05 (disclosed 2026-06-05/06-06).

Background

The article is an SEC Form 4 insider transaction disclosure for Hinge Health, reported by a director.

Company-level read

Ticker impact

$HNGENeutralMedium confidence
Context

Hinge Health director Mecklenburg Gabriel M.I. sold $3.24M of HNGE shares via an open-market transaction under a 10b5-1 plan.

Expected impact

Low, likely limited to short-term sentiment/flow effects; directionally mixed given the stated 10b5-1 plan.

Evidence & confidence

The filing is a routine Form 4 open-market sale by a director, explicitly tied to a pre-arranged 10b5-1 plan, which typically reduces interpretive weight versus discretionary selling.

Market effects

Minimal; single-company insider transaction without broader sector signal.

None indicated.

None indicated.

Counterpoint

Because the sale is under a 10b5-1 plan, it may reflect scheduled liquidity rather than bearish expectations.

Key entities

  • Hinge Health, Inc.

    Public company whose director disclosed an open-market sale of shares under a 10b5-1 plan.

  • Mecklenburg Gabriel M.I.

    Director who sold 49,470 shares for ~$3.24M; holdings after transaction were 530 shares.

Related articles

$HNGEHighAI 9/10

Why is Hinge Health stock surging today?

Hinge Health (HNGE) shares rose 11.6% after the company reported Q2 2026 revenue of $212.8M (+53% YoY) and non-GAAP diluted EPS of $0.59 vs $0.13 consensus. Free cash flow exceeded $100M. Hinge raised FY2026 revenue guidance to $818M-$824M and Q3 guidance to $223M-$225M, and agreed to buy Cylinder Health for $105M cash. Analysts lifted price targets.

$HNGELowAI 8/10

Jim Cramer Says Hinge Health “Delivered a True Blowout Set of Numbers”

On Jim Cramer’s “Mad Money,” he discussed Hinge Health (NYSE:HNGE) after the company reported strong results. Cramer said revenue rose 47% year over year, margins beat expectations, and earnings topped estimates. He noted management raised current-quarter guidance and substantially lifted the full-year forecast, and the stock jumped about 10% in one session, then traded sideways.